Written by :
Published on :
A recent study conducted by Nova Southeastern University in Florida found that a disproportionate number of poker players took performance-enhancement substances, the most common of which was amphetamines or dextroamphetamines, followed by benzodiazepines (tranquilizers), hydrocodone (a painkiller), and methylphenidate (usually used to treat attention deficit disorders).
Some 28 percent of the study group claimed to have used such drugs. Anabolic steroid usage was not included as part of the study.
73 percent of those who used the performance enhancement substances said it was to help them focus or concentrate.
Regarding how they obtained these drugs, 52 percent of the respondents stated that they were given the medications by players or purchased them from fellow players. Another 10 percent said they obtained the drugs online. Only 38 percent claimed to have actual doctor's prescriptions.
71 percent of the individuals surveyed said they used caffeine, 51 percent drank energy drinks, 34 percent smoked marijuana while only 30 percent claimed to drink alcohol.
"The use of these substances could allow poker players to stay awake longer, as well as focus and concentrate better, which would be a competitive advantage," said Kevin Clauson, an associate professor at NSU's college of pharmacy, in a news release. Clauson, the principle investigator in the study, added, "Stamina is important for any poker player because tournament poker and cash games can go on for many hours."
Ace King, Gambling911.com
